Oral supplementation of propionyl-l-carnitine reduces body weight and hyperinsulinaemia in obese Zucker rats
Without a provider review, these contraindications may not be identified before treatment begins
However, extensive clinical trials are needed for validation
In the 64-week OASIS 4 trial (307 adults), mean weight loss was 13.6% under the treatment-policy analysis and 16.6% among participants who stayed on treatment, versus about 2% on placebo
doi: 10.1016/j.jid.2020.11.034
While the role of adipose tissue as a central source of energy has been recognized for centuries, in the past decade, it has become increasingly clear that adipose tissue also displays characteristics of an endocrine organ releasing a number of adipose tissue-specific factors, known as adipokines